EYLEA™ (aflibercept) Injection and ARCALYST® (rilonacept) exemplify Regeneron's commitment to discover, invent, develop, manufacture, and commercialize important medicines for patients suffering from serious diseases.
More information on EYLEA
Full U.S. Prescribing Information for EYLEA
More information on ARCALYST
Full U.S. Prescribing Information for ARCALYST
The product information in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

